Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Kohoutova

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 11, 2018
Science in Focus: The Microbiome and Cancer TherapyJ L Alexander, D Kohoutova, N Powell
Folia Microbiologica|November 28, 2015
Anti-Outer membrane protein C antibodies in colorectal neoplasiaD Kohoutova, M Drahosova, M Cihak, et al.
United European Gastroenterology Journal|May 14, 2019
Endoscopic treatment of chronic pancreatitis in pediatric population: Long-term efficacy and safetyD Kohoutova, A Tringali, G Papparella, et al.
ESMO Open|March 22, 2024
Phase II trial of domatinostat (4SC-202) in combination with avelumab in patients with previously treated advanced mismatch repair proficient oesophagogastric and colorectal adenocarcinoma: EMERGEE Cartwright, S Slater, C Saffery, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 11, 2018
Science in Focus: The Microbiome and Cancer TherapyJ L Alexander, D Kohoutova, N Powell
Folia Microbiologica|November 28, 2015
Anti-Outer membrane protein C antibodies in colorectal neoplasiaD Kohoutova, M Drahosova, M Cihak, et al.
United European Gastroenterology Journal|May 14, 2019
Endoscopic treatment of chronic pancreatitis in pediatric population: Long-term efficacy and safetyD Kohoutova, A Tringali, G Papparella, et al.
ESMO Open|March 22, 2024
Phase II trial of domatinostat (4SC-202) in combination with avelumab in patients with previously treated advanced mismatch repair proficient oesophagogastric and colorectal adenocarcinoma: EMERGEE Cartwright, S Slater, C Saffery, et al.
Pageof 1